Story perspectives

GLP-1 Drugs Slash Heart Disease Risk, But Access Shrinks

9/10/2025

Summary

GLP-1 Drugs Transform Health

GLP-1 drugs, such as Ozempic and Mounjaro, significantly lower cardiovascular disease risk, reducing early heart disease death by nearly 50%.
The global weight loss drug market has reached $58 billion, driven by demand for GLP-1 medications that aid both weight loss and heart health.
GLP-1 drugs are now deemed more cost-effective than lifestyle changes, though affordability remains a major concern for patients.
The WHO has included GLP-1 drugs in its Essential Medicines list to promote wider access, particularly in underserved regions.
Recent insurance coverage changes are restricting access to these medications, leading to frustration among patients and healthcare providers.

Summary

Dr. Grant Advocates Health

Dr. Donald Grant highlights the crucial role of sleep in weight loss, recommending seven to nine hours per night to curb cravings.
He advises setting specific fitness goals, such as exercising three times weekly, to support weight management and heart health.
The shift from summer to autumn is an opportune moment to embrace healthier habits and reduce ultra-processed foods.
Dr. Grant promotes active hobbies like hiking and swimming to boost motivation and mental well-being in colder months.
He cautions that summer indulgences can hinder weight management, urging a renewed focus on health as the year concludes.

1 of 2

GLP-1 Drugs Transform Health

GLP-1 drugs, such as Ozempic and Mounjaro, significantly lower cardiovascular disease risk, reducing early heart disease death by nearly 50%.
The global weight loss drug market has reached $58 billion, driven by demand for GLP-1 medications that aid both weight loss and heart health.
GLP-1 drugs are now deemed more cost-effective than lifestyle changes, though affordability remains a major concern for patients.
The WHO has included GLP-1 drugs in its Essential Medicines list to promote wider access, particularly in underserved regions.
Recent insurance coverage changes are restricting access to these medications, leading to frustration among patients and healthcare providers.

1 / 2